Cooper Companies Inc
NYSE:COO
Cooper Companies Inc
NYSE:COO
Price:
97.9 USD
2.02%
Market Closed
Updated:
May 16, 2024
Cooper Companies Inc
Research & Development
|
Cooper Companies Inc
Research & Development Peer Comparison
Comparables:
HAE
XRAY
ALGN
LNTH
MMSI
Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Cooper Companies Inc
NYSE:COO
|
Research & Development
-$145.3m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-9%
|
|
|
Haemonetics Corp
NYSE:HAE
|
Research & Development
-$53.8m
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-2%
|
|
|
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
Research & Development
-$180m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Align Technology Inc
NASDAQ:ALGN
|
Research & Development
-$351.2m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
-22%
|
|
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
Research & Development
-$95.2m
|
CAGR 3-Years
-35%
|
CAGR 5-Years
-40%
|
CAGR 10-Years
-16%
|
|
|
Merit Medical Systems Inc
NASDAQ:MMSI
|
Research & Development
-$84.4m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-10%
|
See Also
What is Cooper Companies Inc's Research & Development?
Research & Development
-145.3m
USD
-145.3m
USD
Based on the financial report for Jan 31, 2024, Cooper Companies Inc's Research & Development amounts to -145.3m USD.
What is Cooper Companies Inc's Research & Development growth rate?
Research & Development CAGR 10Y
-9%
-9%
Over the last year, the Research & Development growth was -26%. The average annual Research & Development growth rates for Cooper Companies Inc have been -16% over the past three years , -11% over the past five years , and -9% over the past ten years .
You don't have any saved screeners yet
